Narra K - Search Results

1

Current Perspectives in Immunotherapy for Liver Cancer.

Lambring CB, Ghabach B, Narra K, Basha R. Lambring CB, et al. Among authors: narra k. Crit Rev Oncog. 2020;25(1):31-46. doi: 10.1615/CritRevOncog.2020034965. Crit Rev Oncog. 2020. PMID: 32865909 Free PMC article.

2

Adult Cancer Survivors' Engagement and Interest in Patient-Centered Research.

Lubas MM, Lu Y, Gehr AW, Ghabach B, Tanna B, Narra K, Brinkman TM, Ojha RP. Lubas MM, et al. Among authors: narra k. Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):329-335. doi: 10.1158/1055-9965.EPI-19-0689. Epub 2019 Nov 18. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31740520 Free PMC article.

3

Targeted Molecular Therapeutic Options for Hepatocellular Carcinoma.

Sridhar S, Sharma I, Sankpal UT, Ghabach B, Narra K, Neerukonda L, Basha R. Sridhar S, et al. Among authors: narra k. Crit Rev Oncog. 2020;25(1):47-55. doi: 10.1615/CritRevOncog.2020034985. Crit Rev Oncog. 2020. PMID: 32865910 Free PMC article. Review.

4

Impact of prognostic factor distributions on mortality disparities for socioeconomically disadvantaged cancer patients.

Lu Y, Gehr AW, Narra K, Lingam A, Ghabach B, Meadows RJ, Ojha RP. Lu Y, et al. Among authors: narra k. Ann Epidemiol. 2022 Jan;65:31-37. doi: 10.1016/j.annepidem.2021.09.014. Epub 2021 Oct 1. Ann Epidemiol. 2022. PMID: 34601096

5

Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system.

Lu Y, Gehr AW, Meadows RJ, Ghabach B, Neerukonda L, Narra K, Ojha RP. Lu Y, et al. Among authors: narra k. BMC Cancer. 2022 May 31;22(1):593. doi: 10.1186/s12885-022-09688-w. BMC Cancer. 2022. PMID: 35641921 Free PMC article.

6

Cardiotoxicity among socioeconomically marginalized breast cancer patients.

Lu Y, Gehr AW, Anikpo I, Meadows RJ, Craten KJ, Narra K, Lingam A, Kamath S, Tanna B, Ghabach B, Ojha RP. Lu Y, et al. Among authors: narra k. Breast Cancer Res Treat. 2022 Oct;195(3):401-411. doi: 10.1007/s10549-022-06695-0. Epub 2022 Aug 15. Breast Cancer Res Treat. 2022. PMID: 35971056 Free PMC article.

7

[No title available]

[No authors listed] [No authors listed] PMID: 36163820

8

Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer.

Desai PP, Narra K, James JD, Jones HP, Tripathi AK, Vishwanatha JK. Desai PP, et al. Among authors: narra k. Cancers (Basel). 2022 Dec 29;15(1):212. doi: 10.3390/cancers15010212. Cancers (Basel). 2022. PMID: 36612209 Free PMC article.

9

Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer.

Narra K, Mullins SR, Lee HO, Strzemkowski-Brun B, Magalong K, Christiansen VJ, McKee PA, Egleston B, Cohen SJ, Weiner LM, Meropol NJ, Cheng JD. Narra K, et al. Cancer Biol Ther. 2007 Nov;6(11):1691-9. doi: 10.4161/cbt.6.11.4874. Epub 2007 Aug 14. Cancer Biol Ther. 2007. PMID: 18032930 Clinical Trial.

10

Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.

Narra K, Borghaei H, Al-Saleem T, Höglund M, Smith MR. Narra K, et al. Leuk Res. 2006 Jan;30(1):109-14. doi: 10.1016/j.leukres.2005.05.017. Epub 2005 Jul 25. Leuk Res. 2006. PMID: 16043218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page